3183 Stock Overview
Through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
WIN-Partners Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,275.00 |
| 52 Week High | JP¥1,344.00 |
| 52 Week Low | JP¥1,012.00 |
| Beta | 0.25 |
| 1 Month Change | 4.17% |
| 3 Month Change | 9.07% |
| 1 Year Change | 12.73% |
| 3 Year Change | 31.58% |
| 5 Year Change | -13.15% |
| Change since IPO | 232.03% |
Recent News & Updates
There May Be Reason For Hope In WIN-Partners' (TSE:3183) Disappointing Earnings
Nov 26
WIN-Partners' (TSE:3183) Dividend Will Be Increased To ¥51.00
Nov 08Shareholder Returns
| 3183 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0% | -2.0% | -1.5% |
| 1Y | 12.7% | -9.4% | 13.7% |
Return vs Industry: 3183 exceeded the JP Healthcare industry which returned -9.4% over the past year.
Return vs Market: 3183 matched the JP Market which returned 13.7% over the past year.
Price Volatility
| 3183 volatility | |
|---|---|
| 3183 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 3183 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3183's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 629 | Hideumi Akizawa | www.win-partners.co.jp |
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment.
WIN-Partners Co., Ltd. Fundamentals Summary
| 3183 fundamental statistics | |
|---|---|
| Market cap | JP¥36.41b |
| Earnings (TTM) | JP¥1.98b |
| Revenue (TTM) | JP¥80.84b |
18.4x
P/E Ratio0.5x
P/S RatioIs 3183 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3183 income statement (TTM) | |
|---|---|
| Revenue | JP¥80.84b |
| Cost of Revenue | JP¥70.91b |
| Gross Profit | JP¥9.92b |
| Other Expenses | JP¥7.95b |
| Earnings | JP¥1.98b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 69.29 |
| Gross Margin | 12.28% |
| Net Profit Margin | 2.45% |
| Debt/Equity Ratio | 0% |
How did 3183 perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield72%
Payout RatioDoes 3183 pay a reliable dividends?
See 3183 dividend history and benchmarks| WIN-Partners dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 30 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 190 days |
Does 3183 pay a reliable dividends?
See 3183 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 06:45 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
WIN-Partners Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|